Related references
Note: Only part of the references are listed.CURRENT CONCEPTS Advances in the Development of Vaccines against Neisseria meningitidis
Lionel K. K. Tan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans
Davide Serruto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus
Marzia M. Giuliani et al.
VACCINE (2010)
A Novel Phase Variation Mechanism in the Meningococcus Driven by a Ligand-Responsive Repressor and Differential Spacing of Distal Promoter Elements
Matteo M. E. Metruccio et al.
PLOS PATHOGENS (2009)
Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines
Peter T. Beernink et al.
INFECTION AND IMMUNITY (2008)
Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody
Jo Anne Welsch et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Functional and specific antibody responses in adult volunteers in new Zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines
E. Wedege et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis
David S. Stephens et al.
LANCET (2007)
A universal vaccine for serogroup B meningococcus
Marzia M. Giuliani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells
B Capecchi et al.
MOLECULAR MICROBIOLOGY (2005)
Meningococcal polysaccharide-protein conjugate vaccines
MD Snape et al.
LANCET INFECTIOUS DISEASES (2005)
Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease
DJ Litt et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870
V Masignani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity
JA Welsch et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
NadA, a novel vaccine candidate of Neisseria meningitidis
M Comanducci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
ME Ramsay et al.
LANCET (2001)
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
M Pizza et al.
SCIENCE (2000)
Share Paper
